Company / FCF Margin
BioRestorative Therapies, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-3031.7%
FY2025
5-year range
-7305.6% / -3031.7%
FY2021-FY2025
Trend
+33.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 10 years, ranging from -14279.8% in FY2017 to -561.3% in FY2016.
Based on SEC 10-K filings.
-3031.7% in FY2025 with a 5-year CAGR of +2317.8%.
Improved from -4527.6% to -3031.7% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +2125.5pp
- 5-Year Change
- +2317.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 33.0% year-over-year.
- Peak fcf margin was recorded in FY2016.
- Lowest fcf margin in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3031.7% | +33.0% |
| FY2024 | -4527.6% | +0.0% |
| FY2023 | -4527.6% | +12.2% |
| FY2022 | -5157.2% | +29.4% |
| FY2021 | -7305.6% | -36.6% |
| FY2020 | -5349.5% | -16.0% |
| FY2019 | -4610.4% | +3.2% |
| FY2018 | -4762.3% | +66.7% |
| FY2017 | -14279.8% | -2444.0% |
| FY2016 | -561.3% | +31.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026